Previous close | 97.06 |
Open | 97.34 |
Bid | 93.00 x 800 |
Ask | 99.80 x 900 |
Day's range | 96.37 - 98.08 |
52-week range | 62.11 - 98.08 |
Volume | |
Avg. volume | 2,272,780 |
Market cap | 24.815B |
Beta (5Y monthly) | 1.22 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (1.65%) |
Ex-dividend date | 21 June 2024 |
1y target est | N/A |
NEW YORK, May 06, 2024--IFF (NYSE: IFF) today announced that Glenn Richter, IFF’s Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after a three-year tenure with the company. A succession process has been initiated to evaluate internal and external candidates to succeed Richter as CFO.
NEW YORK, May 06, 2024--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2024.
IFF, a global leader in food and beverage, home and personal care and health, will introduce its full suite of plant-based and cellulosic-derived solutions for dietary supplements and over-the-counter (OTC) drugs at Vitafoods Europe 2024. This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.